The Press Release Resource

At least three lawsuits were filed by investors in NASDAQ:ILMN shares against members of the board of directors of Illumina, Inc. The plaintiff alleges the defendants breached their fiduciary duties by, among other things, failing to get the best price for Illumina shareholders and their refusal to engage in negotiations or any substantive dialogue with …

The Shareholders Foundation announces that a second lawsuit was filed by another investor in NASDAQ:ILMN shares against members of the board of directors of Illumina, Inc. The plaintiff alleges the defendants breached their fiduciary duties by, among other things, failing to get the best price for Illumina shareholders and their refusal to engage in negotiations …

The Shareholders Foundation announces that an investor in shares of Illumina, Inc. (NASDAQ:ILMN) filed a lawsuit in State Court against directors of Illumina, Inc. alleged they breached their fiduciary duties to maximize shareholder value after Roche proposed to takeover Illumina for $44.50 per share. Investors who purchased Illumina, Inc. (NASDAQ:ILMN) shares prior to January 24, …

From: Jeffrey Sussman, Inc. Marketing Public Relations 249 East 48 Street New York, NY 10017 For: Ysan Roche FOR IMMEDIATE RELEASE Contact: Jeffrey Sussman 212-421-4475 marketingpro@aol.com www.powerpublicity.com Poster of Unknown Music, Fashion, Film Artist Fires Up Internet Sales New York, NY — She goes by the name Ysan Roche; she has written dozens of songs …

As a leading biology CRO focusing exclusively on early drug discovery and development services, GenScript provides a comprehensive portfolio of services that include Bio-Reagent, Bio-Assay, Lead Optimization, and Antibody Drug Development.